Oncobiologics (NASDAQ: ONS) and CytRx (NASDAQ:CYTR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations.
Insider and Institutional Ownership
Get Oncobiologics alerts:
11.5% of Oncobiologics shares are owned by institutional investors. Comparatively, 4.7% of CytRx shares are owned by institutional investors. 33.5% of Oncobiologics shares are owned by company insiders. Comparatively, 5.3% of CytRx shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Analyst Recommendations
This is a summary of recent ratings and target prices for Oncobiologics and CytRx, as provided by MarketBeat.
Hot Medical Stocks To Own For 2019: First Commonwealth Financial Corporation(FCF)
Advisors’ Opinion:
- [By Joseph Griffin]
Get a free copy of the Zacks research report on First Commonwealth Financial (FCF)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Get a free copy of the Zacks research report on First Commonwealth Financial (FCF)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Barclays PLC increased its holdings in First Commonwealth Financial (NYSE:FCF) by 24.3% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 33,717 shares of the bank’s stock after buying an additional 6,593 shares during the period. Barclays PLC’s holdings in First Commonwealth Financial were worth $476,000 as of its most recent SEC filing.
Hot Medical Stocks To Own For 2019: Equinix Inc.(EQIX)
Advisors’ Opinion:
- [By Lee Jackson]
This is one of the larger cap companies in the data center arena and a top play for more conservative accounts. Equinix Inc. (NASDAQ: EQIX) provides data center services to protect and connect the information assets for the enterprises, financial services companies, and content and network providers primarily in the Americas, Europe, the Middle East, Africa and the Asia-Pacific.
- [By Max Byerly]
Get a free copy of the Zacks research report on Equinix (EQIX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Credit Suisse Group set a $525.00 price objective on Equinix (NASDAQ:EQIX) in a research report report published on Friday. The firm currently has a buy rating on the financial services provider’s stock.
- [By Lee Jackson]
This is one of the larger capitalization companies in the data center industry. Equinix Inc. (NASDAQ: EQIX)provides data center services to protect and connect the information assets for the enterprises, financial services companies, and content and network providers primarily in the Americas, Europe, the Middle East, Africa and the Asia-Pacific.
Hot Medical Stocks To Own For 2019: Jack Henry & Associates Inc.(JKHY)
Advisors’ Opinion:
- [By Ethan Ryder]
Whittier Trust Co. of Nevada Inc. raised its position in Jack Henry & Associates (NASDAQ:JKHY) by 42.5% in the first quarter, Holdings Channel reports. The fund owned 3,154 shares of the technology company’s stock after buying an additional 940 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in Jack Henry & Associates were worth $381,000 as of its most recent SEC filing.
- [By Ethan Ryder]
Stifel Financial Corp increased its position in Jack Henry & Associates, Inc. (NASDAQ:JKHY) by 12.8% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 61,616 shares of the technology company’s stock after acquiring an additional 6,990 shares during the period. Stifel Financial Corp’s holdings in Jack Henry & Associates were worth $7,436,000 as of its most recent SEC filing.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Jack Henry & Associates (JKHY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Hot Medical Stocks To Own For 2019: KKR(KKR)
Advisors’ Opinion:
- [By WWW.GURUFOCUS.COM]
For the details of Jeff Ubben’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Jeff+Ubben
These are the top 5 holdings of Jeff UbbenTwenty-First Century Fox Inc (FOX) – 53,326,334 shares, 18.41% of the total portfolio. Alliance Data Systems Corp (ADS) – 5,877,400 shares, 15.07% of the total portfolio. CBRE Group Inc (CBG) – 24,916,923 shares, 10.92% of the total portfolio. Shares reduced by 13.72%KKR & Co LP (KKR) – 47,750,000 shares, 10.18% of the total portfolio. Shares added by 4.82%Morgan Stanley (MS) – 17,959,620 shares,
- [By Tim Melvin]
Much of my investing philosophy today was learned by studying KKR & Co. LP (NYSE: KKR), Bain Capital, and other private equity firms.
Most of the firms collect a 2% management fee and a 20% incentive fee on realized profits.
- [By ]
In the Lightning Round, Cramer was bullish on Spotify (SPOT) , Alkermes (ALKS) , Johnson & Johnson (JNJ) , Thermo Fisher Scientific (TMO) , Sorrento Therapeutics (SRNE) , NVIDIA (NVDA) , Nucor, Eli Lilly (LLY) and Kohlberg Kravis Roberts (KKR) .
Hot Medical Stocks To Own For 2019: Polaris Industries Inc.(PII)
Advisors’ Opinion:
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Polaris Industries (PII)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
SevenBridge Financial Group LLC lowered its stake in shares of Polaris Industries Inc. (NYSE:PII) by 31.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,432 shares of the company’s stock after selling 1,129 shares during the quarter. SevenBridge Financial Group LLC’s holdings in Polaris Industries were worth $279,000 at the end of the most recent reporting period.
- [By Rich Duprey]
What’s at stake is more than just bragging rights about which motorcycle company has the better racing team. In an industry suffering from flagging sales, race results highlight each bike maker’s technology, innovation, and prowess in building a top performance machine. And that could help provide an edge at dealerships. With Harley once again falling behind Indian’s ownerPolaris Industries (NYSE:PII) in the early going, it could give Indian the momentum to keep driving sales higher.
Hot Medical Stocks To Own For 2019: EMCORE Corporation(EMKR)
Advisors’ Opinion:
- [By Max Byerly]
News stories about EMCORE (NASDAQ:EMKR) have been trending somewhat positive this week, according to Accern Sentiment. The research group identifies positive and negative media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. EMCORE earned a news sentiment score of 0.10 on Accern’s scale. Accern also gave media stories about the semiconductor company an impact score of 45.6118508960632 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
- [By Peter Graham]
Small cap fiber-optic networking product Applied Optoelectronics (NASDAQ: AAOI), a potential peer of EMCORE Corporation (NASDAQ: EMKR), Finisar Corporation (NASDAQ: FNSR) and Oclaro Inc (NASDAQ: OCLR), is themostshorted stock on theNASDAQ with short interest of 62.65% according to Highshortnterest.com.
